Journal
AMERICAN JOURNAL OF KIDNEY DISEASES
Volume 71, Issue 1, Pages 65-74Publisher
W B SAUNDERS CO-ELSEVIER INC
DOI: 10.1053/j.ajkd.2017.07.015
Keywords
-
Categories
Funding
- National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)/National Institutes of Health [T32-DK063687, U01-DK61212, U01-DK61230, U01-DK61239, U01-DK61242, U01-DK61254]
- National Center for Research Resources (NCRR) [M01-RR00036, M01-RR00043-45, M01-RR00069, M01-RR00084, M01-RR01066, M01-RR00125, M01-RR14467]
- NCRR [UL1-RR024134, UL1-RR024139, UL1-RR024153, UL1-RR024989, UL1-RR024992, UL1-RR025758, UL1-RR025780]
- NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR002345] Funding Source: NIH RePORTER
- NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025758] Funding Source: NIH RePORTER
- NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK036836, P30DK048520, T32DK063687, U01DK061230] Funding Source: NIH RePORTER
Ask authors/readers for more resources
Background: Diabetic kidney disease is a major cause of premature mortality in type 2 diabetes mellitus (T2DM). Worsening insulin sensitivity independent of glycemic control may contribute to the development of diabetic kidney disease. We investigated the longitudinal association of insulin sensitivity with hyper-filtration and increased albumin excretion in adolescents with T2DM. Study Design: Observational prospective cohort study. Setting & Participants: 532 TODAY (Treatment Options for Type 2 Diabetes in Adolescents and Youth) participants aged 12 to 17 years with T2DM duration less than 2 years at baseline. The TODAY Study was a multicenter randomized clinical trial that examined the efficacy of 3 treatment regimens (metformin monotherapy, metformin plus rosiglitazone, or metformin plus an intensive lifestyle intervention program) to achieve durable glycemic control. Predictors: Natural log-transformed estimated insulin sensitivity (reciprocal of fasting insulin), hemoglobin A(1c) concentration, age, race-ethnicity, treatment group, body mass index, loss of glycemic control, and hypertension. Outcomes: Hyperfiltration was defined as 99th percentile or higher of estimated glomerular filtration rate (>= 140 mL/min/1.73 m(2)) when referenced to healthy adolescents (NHANES 1999-2002) and albumin-creatinine ratio >= 30 mu g/mg at 3 consecutive annual visits. Results: Hyperfiltration was observed in 7.0% of participants at baseline and in 13.3% by 5 years, with a cumulative incidence of 5.0% over 5 years. The prevalence of increased albumin excretion was 6% at baseline and 18% by 5 years, with a cumulative incidence of 13.4%. There was an 8% increase in risk for hyperfiltration per 10% lower estimated insulin sensitivity in unadjusted and adjusted models (P = 0.01). Increased albumin excretion was associated with hemoglobin A(1c) concentration, but not estimated insulin sensitivity. Limitations: Longer follow-up is needed to capture the transition from hyperfiltration to rapid glomerular filtration rate decline in youth-onset T2DM. Conclusions: Lower estimated insulin sensitivity was associated with risk for hyperfiltration over time, whereas increased albumin excretion was associated with hyperglycemia in youth-onset T2DM.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available